Development Entity Sample Clauses

The 'Development Entity' clause defines the party responsible for overseeing and executing the development aspects of a project, such as construction or property improvements. This clause typically identifies the entity by name and may outline its specific roles, obligations, and authority within the project, including managing contractors, securing permits, and ensuring compliance with relevant regulations. By clearly designating the development entity, this clause ensures accountability and streamlines project management, reducing confusion over responsibilities and facilitating smoother project execution.
Development Entity. The Developer shall submit to CADA for review and approval executed development formation documents for the specific development team or entity that is to enter into the DDA by . In the event the Developer fails to submit or resubmit the required development entity formation documents to CADA within the time set forth in this Section, CADA may, at its option, terminate this Agreement by written notice to the Developer. Neither party shall have any further rights against or liability to the other under this Agreement.
Development Entity. CADA shall review and either approve or disapprove the executed development entity formation documents submitted by the Developer in accordance with Section 3.5 of this Agreement within fourteen (14) days of the date such information is received by CADA. In the event CADA disapproves the development entity formation documents, CADA shall give the Developer written notice of such disapproval. The Developer shall then have ten (10) working days from the date of the notice to resubmit new documentation in accordance with Section 3.5.
Development Entity. The Developer shall make full disclosure to the Village of all information pertinent to the ownership, control and financial capacity of the development entity that is proposed to serve as developer under the Agreement.
Development Entity. The Developer shall make full disclosure to the Agency of all information pertinent to the ownership, control and financial capacity of the development entity that is proposed to serve as developer under the DDA.

Related to Development Entity

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for one Product in the Field in [***]. Pfizer will have no other diligence obligations with respect to the Development or Regulatory Approval of Products under this Agreement.

  • Development Within twenty (20) Working Days after the Commencement Date and in accordance with paragraphs 3.10 to 3.12 (Amendment and Revision), the Contractor will prepare and deliver to the Authority for approval the full and final Security Plan which will be based on the draft Security Plan set out in Appendix B.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Development Efforts 4.2.1 Hana shall use Commercially Reasonable Efforts to Develop each Product in the Territory (including carrying out its responsibilities under the Development Plan) to: (a) conduct or cause to be conducted the necessary and appropriate clinical trials as necessary to obtain and maintain Regulatory Approvals for each Product; and (b) prepare, file and prosecute or cause to be prepared, filed and prosecuted the Regulatory Submission for each Product. 4.2.2 Hana will provide INEX with written reports to keep INEX fully informed of the progress of the Development of each Product as follows: (a) at the close of each Calendar Quarter during the first twenty-four (24) months following the Effective Date of the Definitive Agreements; and (b) on or before June 31 and December 31 of each and every calendar year thereafter.